Randomized controlled trials are not appropriate for imaging technology evaluation

Journal of Nuclear Medicine

Volumn 41, Issue 7, 2000, Pages 1125-1126

  Valk, Peter E ^a,b  

^a Northern California PET Imaging Ctr   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; EDITORIAL; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

DIAGNOSTIC IMAGING; HUMANS; RANDOMIZED CONTROLLED TRIALS; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 0033912056     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (7)

1. Fryback DG, Thornbury JR. The efficacy of diagnostic imaging. Med Decis Making. 1991;11:88-94.
2. Thombury JR, Kido DK, Mushlin AI, Phelps CE. Mooney C, Fryback DG. Increasing the scientific quality of clinical efficacy studies of magnetic resonance imaging. Invest Radiol. 1991;26:829-833.
3. Fineberg HV. Evaluation of computed tomography: achievement and challenge. AJR. 1978;131:1-4.
4. Begg CB, McNeil BJ. Assessment of radiologic tests; control of bias and other design considerations. Radiology, 1988;167:565-569.
5. Department of Clinical Epidemiology and Biostatistics, McMaster University Health Sciences Center. How to read journals: II. To learn about a diagnostic test. Can Med Assoc J. 1981;124:703-710.
6. Management Decision and Research Center Technology Assessment Program. Positron Emission Tomography: Descriptive Analysis of Experience with PET in VA and Systemic Reviews: FDG PET as a Diagnostic Test for Cancer and Alzheimer's Disease. Washington, DC: Veterans Health Administration, Department of Veterans Affairs; 1996.
7. Cook DK, Guyatt GH, Laupacis A, Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest. 1991; 102(suppl):305S-311S.